| Primary Care Respiratory Society UK (PCRS-UK) |
![]() |
|||||||||||
| |||||||||||
|
|
COPD National Strategy
Identification and Diagnosis Further resources for professionals PCRS-UK: Opinion: Spirometry Opinion: COPD review Opinion: Pulse oximetry in Primary Care Protocol: Protocol for the use of spirometry in primary care Patient Group Direction: The supply/administration of salbutamol for reversibility testing in primary care by a designated healthcare professional Svanes, C., Sunyer, J., Plana, E., Dharmage, S., Heinrich, J., Jarvis, D. et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20 Price, D., Crockett, A., Arne, M., Garbe, B., Jones, R. C., Kaplan, A. et al. Spirometry in primary care case-identification, diagnosis and management of COPD. Prim.Care Respir J 2009; 18: 216-223 Celli BR, Cote CG, Marin JM, Casanova C, Montes de OM, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. New Eng J Med 2004; 350: 1005-1012 Jones RC, Donaldson GC, Chavannes NH, Kida K, Dickson-Spillmann M, Harding S et al. Derivation and Validation of a Composite Index of Severity in Chronic Obstructive Pulmonary Disease - The DOSE Index. Am J Respir Crit Care Med 2009; 180: 1189-1195 Levy ML, Quanjer PH, Booker R, Cooper BG, Holmes S, Small I. Diagnostic spirometry in primary care: Proposed standards for general practice compliant with American Thoracic Society and European Respiratory Society recommendations: a General Practice Airways Group document, in association with the Association for Respiratory Technology & Physiology and Education for Health. Prim Care Respir J 2009; 18: 130-147 |
|
Author: Dr Hilary Pinnock, University of Edinburgh, and Whitstable Medical Practice, Kent |
Editor: Dr Mark Levy, Kingsbury, London
This COPD National Strategy Quick Reference Guide is provided to you by the Primary Care Respiratory Society UK (PCRS-UK) and is an interpretation of the document Consultation on a Strategy for Chronic Obstructive Pulmonary Disease (COPD) in England (February 2010) written by the Department of Health. This Quick Reference Guide has been supported by an educational grant from Allen & Hanburys, the specialist respiratory division of GlaxoSmithKline, AstraZeneca UK Ltd and Boehringer Ingelheim Ltd/Pfizer Ltd. The views expressed in the materials are not necessarily those of either the Department of Health, the sponsors or the Primary Care Respiratory Society UK (PCRS-UK). © PCRS-UK |
|
|